Celebrating 20 years
Brain imaging abnormalities and outcome after acute ischaemic stroke: the ENCHANTED trial
Building back better after COVID-19: The research agenda
The wider benefits of SGLT2 inhibitors
Donate
The George Institute is producing high-quality, high-impact evidence to inform policy, guidelines and practices across the world. We are engaging with key decision makers to enact real change in health policy and practice where it is needed most.
